Your browser doesn't support javascript.
loading
Predicting risk of undiagnosed COPD: development and validation of the TargetCOPD score.
Haroon, Shamil; Adab, Peymane; Riley, Richard D; Fitzmaurice, David; Jordan, Rachel E.
Afiliación
  • Haroon S; Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
  • Adab P; Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
  • Riley RD; Research Institute for Primary Care and Health Sciences, Primary Care Sciences, Keele University, Keele, UK.
  • Fitzmaurice D; Warwick Medical School, Coventry, UK.
  • Jordan RE; Institute of Applied Health Research, University of Birmingham, Birmingham, UK r.e.jordan@bham.ac.uk.
Eur Respir J ; 49(6)2017 06.
Article en En | MEDLINE | ID: mdl-28642308
Chronic obstructive pulmonary disease (COPD) is greatly underdiagnosed worldwide and more efficient methods of case-finding are required. We developed and externally validated a risk score to identify undiagnosed COPD using primary care records.We conducted a retrospective cohort analysis of a pragmatic cluster randomised controlled case-finding trial in the West Midlands, UK. Participants aged 40-79 years with no prior diagnosis of COPD received a postal or opportunistic screening questionnaire. Those reporting chronic respiratory symptoms were assessed with spirometry. COPD was defined as presence of relevant symptoms with a post-bronchodilator forced expiratory volume in 1 s/forced vital capacity ratio below the lower limit of normal. A risk score was developed using logistic regression with variables available from electronic health records for 2398 participants who returned a postal questionnaire. This was externally validated among 1097 participants who returned an opportunistic questionnaire to derive the c-statistic, and the sensitivity and specificity of cut-points.A risk score containing age, smoking status, dyspnoea, prescriptions of salbutamol and prescriptions of antibiotics discriminated between patients with and without undiagnosed COPD (c-statistic 0.74, 95% CI 0.68-0.80). A cut-point of ≥7.5% predicted risk had a sensitivity of 68.8% (95% CI 57.3-78.9%) and a specificity of 68.8% (95% CI 65.8.1-71.6%).A novel risk score using routine data from primary care electronic health records can identify patients at high risk for undiagnosed symptomatic COPD. This score could be integrated with clinical information systems to help primary care clinicians target patients for case-finding.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Atención Primaria de Salud / Espirometría / Enfermedad Pulmonar Obstructiva Crónica / Errores Diagnósticos Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Eur Respir J Año: 2017 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Atención Primaria de Salud / Espirometría / Enfermedad Pulmonar Obstructiva Crónica / Errores Diagnósticos Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Eur Respir J Año: 2017 Tipo del documento: Article